Milgamma N (Benfotiamine, Cyanocobalamin, Pyridoxine Hydrochloride)

Benfotiamine, cyanocobalamin and pyridoxine hydrochloride, the active ingredients in Milgamma N, are water‑soluble and lipid‑soluble B‑vitamins presented as an oral tablet for systemic use. They are employed to support nerve metabolism, reduce oxidative stress and correct vitamin deficiencies in adults with diabetic or alcohol‑related neuropathy.

GNH USA supplies Milgamma N as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU manufacturing standards and provides regulatory documentation for global distribution.

Milgamma N is used to address conditions affecting peripheral nerves and vitamin B deficiencies.

- Diabetic peripheral neuropathy: helps alleviate nerve pain and improve sensory function - Alcohol‑induced neuropathy: supports nerve regeneration and reduces symptoms - Vitamin B12 deficiency anemia: restores normal red blood cell production - Peripheral nerve dysfunction of various etiologies: enhances nerve conduction and reduces oxidative damage

Milgamma N may cause adverse reactions, which are generally mild but can be serious in rare cases.

Common Side Effects: - Nausea: mild stomach upset after ingestion - Headache: transient mild headache - Abdominal discomfort: occasional stomach cramps - Skin rash: mild erythema or itching - Dizziness: brief light‑headedness

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention - Stevens‑Johnson syndrome: rare severe skin eruption - Hemolytic anemia: especially in patients with G6PD deficiency - Severe liver enzyme elevation: monitor hepatic function if symptoms arise

When prescribing Milgamma N, consider the following precautions to ensure safe use.

- Assess vitamin B12 status: confirm deficiency before initiating therapy - Monitor blood glucose: observe for any impact on diabetic control - Avoid in known hypersensitivity: discontinue if allergic reaction occurs - Use with caution in renal impairment: adjust dose if necessary - Do not exceed recommended dose: follow prescriber instructions - Store at room temperature: keep in the original pack, protect from moisture and direct sunlight

Milgamma N can interact with certain medicines; awareness of these interactions helps prevent complications.

Major Interactions (Avoid): - Methotrexate: may increase toxicity and bone‑marrow suppression - Phenytoin: reduces pyridoxine levels, potentially diminishing efficacy - Chloramphenicol: may impair cyanocobalamin utilization

Moderate Interactions (Monitor Closely): - Metformin: can mask vitamin B12 deficiency, requiring periodic monitoring - Antacids or proton‑pump inhibitors: decrease cyanocobalamin absorption - Alcohol: may exacerbate neuropathy and increase risk of adverse effects